These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22894158)

  • 41. [Tuftsin--new analogues and properties].
    Wardowska A; Dzierzbicka K; Myśliwski A
    Postepy Biochem; 2007; 53(1):60-5. PubMed ID: 17718389
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis of Diverse N-Substituted Muramyl Dipeptide Derivatives and Their Use in a Study of Human NOD2 Stimulation Activity.
    Chen KT; Huang DY; Chiu CH; Lin WW; Liang PH; Cheng WC
    Chemistry; 2015 Aug; 21(34):11984-8. PubMed ID: 26226896
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Poly(lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells.
    Yoshida M; Babensee JE
    J Biomed Mater Res A; 2004 Oct; 71(1):45-54. PubMed ID: 15368253
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Platelet factor 4 in conjunction with IL-4 directs differentiation of human monocytes into specialized antigen-presenting cells.
    Fricke I; Mitchell D; Petersen F; Böhle A; Bulfone-Paus S; Brandau S
    FASEB J; 2004 Oct; 18(13):1588-90. PubMed ID: 15319366
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunomodulation of macrophages by muramyl peptides: recent findings concerning somnogenic activity of muramyl peptides and monokine.
    Leclerc C; Chedid L
    Int J Tissue React; 1984; 6(3):215-8. PubMed ID: 6332794
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epigallocatechin gallate affects human dendritic cell differentiation and maturation.
    Yoneyama S; Kawai K; Tsuno NH; Okaji Y; Asakage M; Tsuchiya T; Yamada J; Sunami E; Osada T; Kitayama J; Takahashi K; Nagawa H
    J Allergy Clin Immunol; 2008 Jan; 121(1):209-14. PubMed ID: 17935769
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Secretion of interleukin-6 (IL-6) by human monocytes stimulated by muramyl dipeptide and tumour necrosis factor alpha.
    Sancéau J; Falcoff R; Beranger F; Carter DB; Wietzerbin J
    Immunology; 1990 Jan; 69(1):52-6. PubMed ID: 1690177
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differences in proinflammatory activity of several immunomodulatory derivatives of muramyl dipeptide (MDP) with special reference to the mechanism of the MDP effects.
    Zídek Z
    Agents Actions; 1992 May; 36(1-2):136-45. PubMed ID: 1414682
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of monomethylfumarate on dendritic cell differentiation.
    Litjens NH; Rademaker M; Ravensbergen B; Thio HB; van Dissel JT; Nibbering PH
    Br J Dermatol; 2006 Feb; 154(2):211-7. PubMed ID: 16433787
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Echinococcus granulosus antigen B impairs human dendritic cell differentiation and polarizes immature dendritic cell maturation towards a Th2 cell response.
    Riganò R; Buttari B; Profumo E; Ortona E; Delunardo F; Margutti P; Mattei V; Teggi A; Sorice M; Siracusano A
    Infect Immun; 2007 Apr; 75(4):1667-78. PubMed ID: 17210662
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human NOD2 Recognizes Structurally Unique Muramyl Dipeptides from Mycobacterium leprae.
    Schenk M; Mahapatra S; Le P; Kim HJ; Choi AW; Brennan PJ; Belisle JT; Modlin RL
    Infect Immun; 2016 Sep; 84(9):2429-38. PubMed ID: 27297389
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Calreticulin is a binding protein for muramyl dipeptide and peptidoglycan in RK13 cells.
    Chen D; Duggan C; Reden TB; Kooragayala LM; Texada DE; Langford MP
    Biochemistry; 2004 Sep; 43(37):11796-801. PubMed ID: 15362864
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Opposite effects of the synthetic adjuvant N-acetyl-muramyl-L-alanyl-D-isoglutamine on the immune response in mice depending on experimental conditions.
    Souvannavong V; Adam A
    Eur J Immunol; 1980 Aug; 10(8):654-6. PubMed ID: 6995138
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The macrophage, target cell of the synthetic adjuvant muramyl dipeptide.
    Fevrier M; Birrien JL; Leclerc C; Chedid L; Liacopoulos P
    Eur J Immunol; 1978 Aug; 8(8):558-62. PubMed ID: 359336
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of configuration of muramyl dipeptide glycoside bond and structure of glycoside aglycon on their capacity to stimulate production of interleukin-1 and tumor necrosis factor by macrophages.
    Kalyuzhin OV; Nelyubov MV; Kalyuzhina EV; Kuzovlev FN; Shkalev MV
    Bull Exp Biol Med; 2002 Sep; 134(3):281-3. PubMed ID: 12512003
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Muramyl dipeptide-induced differential gene expression in NOD2 mutant and wild-type Crohn's disease patient-derived dendritic cells.
    Zelinkova Z; van Beelen AJ; de Kort F; Moerland PD; Ver Loren van Themaat E; te Velde AA; van Deventer SJ; de Jong EC; Hommes DW
    Inflamm Bowel Dis; 2008 Feb; 14(2):186-94. PubMed ID: 17941075
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stimulation of migration of human monocytes by bacterial cell walls and muramyl peptides.
    Ogawa T; Kotani S; Fukuda K; Tsukamoto Y; Mori M; Kusumoto S; Shiba T
    Infect Immun; 1982 Dec; 38(3):817-24. PubMed ID: 7152675
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mature human Langerhans cells derived from CD34+ hematopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either single peptide presentation or cross-priming, than do dermal-interstitial or monocyte-derived dendritic cells.
    Ratzinger G; Baggers J; de Cos MA; Yuan J; Dao T; Reagan JL; Münz C; Heller G; Young JW
    J Immunol; 2004 Aug; 173(4):2780-91. PubMed ID: 15294997
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Macrophage activation for antitumour function by muramyl dipeptide-protein conjugates.
    Tabata Y; Ikada Y
    J Pharm Pharmacol; 1990 Jan; 42(1):13-9. PubMed ID: 1969943
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel immunostimulator, N-[alpha-O-benzyl-N-(acetylmuramyl)-L-alanyl-D-isoglutaminyl]-N6-trans-(m-nitrocinnamoyl)-L-lysine, and its adjuvancy on the hepatitis B surface antigen.
    Yang HZ; Xu S; Liao XY; Zhang SD; Liang ZL; Liu BH; Bai JY; Jiang C; Ding J; Cheng GF; Liu G
    J Med Chem; 2005 Aug; 48(16):5112-22. PubMed ID: 16078831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.